Brentuximab vedotin: Powder for I.V. infusion 50 mg; Adcetris® Page last updated: 9 November 2018 Public Summary Document (PSD) July 2018 PBAC Meeting - (PDF 191 KB) Public Summary Document (PSD) July 2018 PBAC Meeting - (Word 77 KB)